A new research study showed that circulating tumor DNA (ctDNA)—genetic material shed from tumors into the bloodstream—can identify stage II colon cancer patients who can most benefit from chemotherapy following surgery and spare other patients the need for this form of treatment.
…
in Health
DNA shed from colon cancers into bloodstream successfully guides chemotherapy after surgery
